BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

876 related articles for article (PubMed ID: 19522736)

  • 1. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction of the melatonin receptor MT1 is disrupted in breast cancer cells by electromagnetic fields.
    Girgert R; Hanf V; Emons G; Gründker C
    Bioelectromagnetics; 2010 Apr; 31(3):237-45. PubMed ID: 19882681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines.
    Lai L; Yuan L; Cheng Q; Dong C; Mao L; Hill SM
    Breast Cancer Res Treat; 2009 Nov; 118(2):293-305. PubMed ID: 18979234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
    Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
    Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation.
    Jawed S; Kim B; Ottenhof T; Brown GM; Werstiuk ES; Niles LP
    Eur J Pharmacol; 2007 Mar; 560(1):17-22. PubMed ID: 17303109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1.
    Chen C; Chang YC; Liu CL; Chang KJ; Guo IC
    Breast Cancer Res Treat; 2006 Jul; 98(2):121-32. PubMed ID: 16752079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells.
    Lapillonne H; Konopleva M; Tsao T; Gold D; McQueen T; Sutherland RL; Madden T; Andreeff M
    Cancer Res; 2003 Sep; 63(18):5926-39. PubMed ID: 14522919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O; Lattrich C; Springwald A; Ortmann O
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
    Ghosh MG; Thompson DA; Weigel RJ
    Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiestrogens modulate MT1 melatonin receptor expression in breast and ovarian cancer cell lines.
    Treeck O; Haldar C; Ortmann O
    Oncol Rep; 2006 Jan; 15(1):231-5. PubMed ID: 16328061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex hormone-binding globulin selectively modulates estradiol-regulated genes in MCF-7 cells.
    Catalano MG; Costantino L; Frairia R; Boccuzzi G; Fortunati N
    Horm Metab Res; 2007 Apr; 39(4):288-94. PubMed ID: 17447168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D; Dembinski TC; Shiu RP
    Cancer Res; 1987 Dec; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression.
    Perera CN; Chin HG; Duru N; Camarillo IG
    J Endocrinol; 2008 Nov; 199(2):221-33. PubMed ID: 18715880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation.
    Masuda H; Otsuka F; Matsumoto Y; Takano M; Miyoshi T; Inagaki K; Shien T; Taira N; Makino H; Doihara H
    Mol Cell Endocrinol; 2011 Aug; 343(1-2):7-17. PubMed ID: 21664418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.